Science Explorer Back to mapMap
Discussion
Institution · Helen DeVos Children's Hospital

Most cited papers from Helen DeVos Children's Hospital

Helen DeVos Children's Hospital

What are the most cited papers from Helen DeVos Children's Hospital?

The most cited paper from Helen DeVos Children's Hospital is "Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study" (Nathan Kuppermann et al., 2009), with 1,645 citations. Next come "Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes" (899) and "Proteogenomic and metabolomic characterization of human glioblastoma" (722).

Showing 50 of 60 papers. Every paper with more than 119 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study Nathan Kuppermann et al. · The Lancet 15 Sep 2009 1,645
2 Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes Richard M. Bergenstal, William V. Tamborlane, Andrew Ahmann et al. · New England Journal of Medicine Open access 29 Jun 2010 899
3 Proteogenomic and metabolomic characterization of human glioblastoma Liang-Bo Wang et al. · Cancer Cell Open access238 authors 11 Feb 2021 722
4 Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's Disease Maria Luisa Escolar, Michele D. Poe, James M. Provenzale et al. · New England Journal of Medicine Open access 18 May 2005 715
5 Fluid Overload and Mortality in Children Receiving Continuous Renal Replacement Therapy: The Prospective Pediatric Continuous Renal Replacement Therapy Registry Scott M. Sutherland, Michael Zappitelli, Steven R. Alexander et al. · American Journal of Kidney Diseases 31 Dec 2009 698
6 Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States Antonia Kwan et al. · JAMA Open access 19 Aug 2014 688
7 Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series Peter Andrija Nigrovic, Melissa L. Mannion, Femke H. M. Prince et al. · Arthritis & Rheumatism 6 Nov 2010 467
8 A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial Infections Nathan Kuppermann et al. · Archives of Pediatrics and Adolescent Medicine Open access 18 Feb 2019 380
9 COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic Marcus S Shaker et al. · The Journal of Allergy and Clinical Immunology In Practice Open access 26 Mar 2020 352
10 Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry Jenise C. Wong, Nicole C. Foster, David M. Maahs et al. · Diabetes Care Open access 11 Jul 2014 324
11 Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial Kevin A. Strauss, Michelle Anne Farrar, Francesco Muntoni et al. · Nature Medicine Open access 17 Jun 2022 318
12 Safety, Tolerability, and Clinical Response After Fecal Transplantation in Children and Young Adults With Ulcerative Colitis Sachin S. Kunde, Angela K. Pham, Sarah Bonczyk et al. · Journal of Pediatric Gastroenterology and Nutrition 29 Mar 2013 318
13 Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group Nita L. Seibel, Peter G. Steinherz, Harland N. Sather et al. · Blood Open access 27 Nov 2007 312
14 Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease Marc P Nicolino et al. · Genetics in Medicine Open access Mar 2009 294
15 Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial Kevin A. Strauss et al. · Nature Medicine Open access 17 Jun 2022 293
16 Juvenile xanthogranuloma: Forms of systemic disease and their clinical implications David R. Freyer, Rosemarie Kennedy, Bruce Bostrom et al. · The Journal of Pediatrics Aug 1996 293
17 A Multicenter, Randomized, Controlled Trial of Dexamethasone for Bronchiolitis Howard M. Corneli et al. · New England Journal of Medicine 25 Jul 2007 290
18 Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial David R. Freyer, Lu Chen, Mark Krailo et al. · The Lancet Oncology Open access 30 Nov 2016 265
19 Identifying Children at Very Low Risk of Clinically Important Blunt Abdominal Injuries James F. Holmes et al. · Annals of Emergency Medicine 31 Jan 2013 249
20 Cast and Splint Immobilization: Complications Matthew Aaron Halanski, Kenneth J. Noonan · Journal of the American Academy of Orthopaedic Surgeons 2008 247
21 Outcome of children less than three years old at diagnosis with non‐metastatic medulloblastoma treated with chemotherapy on the “Head Start” I and II protocols Girish Dhall, Howard Grodman, Lingyun Ji et al. · Pediatric Blood & Cancer 21 Feb 2008 245
22 The genomic landscape of tuberous sclerosis complex Katie R. Martin, Wanding Zhou, Megan J. Bowman et al. · Nature Communications Open access 15 Jun 2017 241
23 Emergent high fatality lung disease in systemic juvenile arthritis Vivian E Saper et al. · Annals of the Rheumatic Diseases Open access 27 Sep 2019 224
24 Association of RNA Biosignatures With Bacterial Infections in Febrile Infants Aged 60 Days or Younger Prashant Mahajan et al. · JAMA Open access 23 Aug 2016 220
25 6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study Ravi Bhatia, Wendy Landier, Lindsey Hageman et al. · Blood Open access 15 May 2014 205
26 Body Fat Percentile Curves for U.S. Children and Adolescents Kelly Rian Laurson, Joey C. Eisenmann, Gregory J. Welk · American Journal of Preventive Medicine 23 Sep 2011 203
27 Therapeutic Role of Anakinra, an Interleukin-1 Receptor Antagonist, in the Management of Secondary Hemophagocytic Lymphohistiocytosis/Sepsis/Multiple Organ Dysfunction/Macrophage Activating Syndrome in Critically Ill Children* Surender Rajasekaran, Katherine A. Kruse, Karen Kovey et al. · Pediatric Critical Care Medicine Open access 27 Feb 2014 199
28 Risk factors associated with mortality and interventions in 472 neonates with interrupted aortic arch: A Congenital Heart Surgeons Society study Brian W. McCrindle, Christo I. Tchervenkov, Igor E. Konstantinov et al. · Journal of Thoracic and Cardiovascular Surgery Open access 30 Dec 2004 193
29 Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy Krzysztof Kiryluk et al. · Nature Genetics Open access188 authors 19 Jun 2023 191
30 Results of the Cord Blood Transplantation Study (COBLT): Outcomes of Unrelated Donor Umbilical Cord Blood Transplantation in Pediatric Patients with Lysosomal and Peroxisomal Storage Diseases Paul Martin, Shelly L. Carter, Nancy A. Kernan et al. · Transplantation and Cellular Therapy Open access 28 Jan 2006 188
31 Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2 Kathleen Chiotos et al. · Journal of the Pediatric Infectious Diseases Society Open access 21 Apr 2020 187
32 Medication Dosing Errors in Pediatric Patients Treated by Emergency Medical Services John D. Hoyle, Alan T. Davis, Kevin Putman et al. · Prehospital Emergency Care 14 Oct 2011 171
33 Development of Youth Aerobic-Capacity Standards Using Receiver Operating Characteristic Curves Gregory J. Welk, Kelly Rian Laurson, Joey C. Eisenmann et al. · American Journal of Preventive Medicine 23 Sep 2011 169
34 A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children Stuart L. Goldstein et al. · Kidney International Open access Nov 2019 168
35 Continuous Renal Replacement Therapy for Children ≤10 kg: A Report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry David J. Askenazi, Stuart L. Goldstein, Rajesh Koralkar et al. · The Journal of Pediatrics Open access 24 Oct 2012 165
36 Racial and Ethnic Disparities and Bias in the Evaluation and Reporting of Abusive Head Trauma Kent P. Hymel et al. · The Journal of Pediatrics Open access 29 Mar 2018 164
37 Neonatal Cranial Ultrasound Lesions and Developmental Delays at 2 Years of Age Among Extremely Low Gestational Age Children Thomas Michael O’Shea et al. · PEDIATRICS Open access Sep 2008 157
38 Surveillance After Initial Surgery for Pediatric and Adolescent Girls With Stage I Ovarian Germ Cell Tumors: Report From the Children's Oncology Group Deborah F. Billmire, John W. Cullen, Frederick J. Rescorla et al. · Journal of Clinical Oncology Open access 7 Jan 2014 156
39 Clinical Trial of Safety and Efficacy of IHN-A21 for the Prevention of Nosocomial Staphylococcal Bloodstream Infection in Premature Infants Mitchell H. DeJonge, David J. Burchfield, Barry T. Bloom et al. · The Journal of Pediatrics 25 Jul 2007 156
40 Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency Anirban Das et al. · Nature Medicine Open access 2022 155
41 Timing of Initiation and Discontinuation of Renal Replacement Therapy in AKI R. T. Noel Gibney, Eric A. J. Hoste, Emmanuel A. Burdmann et al. · Clinical Journal of the American Society of Nephrology 5 Mar 2008 149
42 HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome Rasheed Gbadegesin et al. · Journal of the American Society of Nephrology Open access 28 Oct 2014 149
43 Therapy of Parapneumonic Effusions in Children: Video-Assisted Thoracoscopic Surgery Versus Conventional Thoracostomy Drainage Beth A. Kurt, Kimberly M. Winterhalter, Robert H. Connors et al. · PEDIATRICS 15 Aug 2006 148
44 A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma Giselle L. Saulnier Sholler et al. · PLoS ONE Open access 27 May 2015 145
45 Care of the Dying Adolescent: Special Considerations David R. Freyer · PEDIATRICS Feb 2004 140
46 Models of care for survivors of childhood cancer Debra L. Friedman, David R. Freyer, Gill Levitt · Pediatric Blood & Cancer 20 Dec 2005 137
47 Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials Nicole Mayer-Hamblett et al. · The Lancet Respiratory Medicine Open access206 authors 4 Nov 2022 136
48 Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study Robert H. Slover, John B. Welsh, Amy B. Criego et al. · Pediatric Diabetes Open access 3 Jul 2011 136
49 The Effect of Vascular Access Location and Size on Circuit Survival in Pediatric Continuous Renal Replacement Therapy: A Report from the PPCRRT Registry Richard M. Hackbarth, Timothy E. Bunchman, Annabelle N. Chua et al. · The International Journal of Artificial Organs Dec 2007 136
50 Post-Transplant High-Dose Cyclophosphamide for the Prevention of Graft-versus-Host Disease Ahmad Samer Al-Homsi, Tara S. Roy, Kelli Cole et al. · Transplantation and Cellular Therapy Open access 23 Aug 2014 131

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.